 |
|
|
|
|
|
|
| The following information (Health Effects, Handling/Disposal, and Ingredients) is taken from the product label and/or the Material Safety Data Sheet (MSDS) prepared by the manufacturer. The National Library of Medicine does not test products nor does it evaluate information from the product label or the MSDS.
|
 |
|
|
|
Health Effects
|
|
From MSDS
IMMEDIATE CONCERNS:
CAUSES EYE IRRITATION
HARMFUL IF SWALLOWED
AVOID BREATHING VAPOR OR SPRAY MIST
AVOID CONTACT WITH SKIN OR CLOTHING
FLAMMABLE
KEEP OUT OF REACH OF CHILDREN
POTENTIAL HEALTH EFFECTS
EYES: This substance causes moderate eye irritation as indicated by possible discomfort, tearing, swelling, redness, and blurred vision.
SKIN: This substance is not expected to cause prolonged or significant skin irritation. If absorbed through the skin, this substance is considered practically non-toxic to internal organs.
INGESTION: Ingestion of a toxic amount of this product can result in irritation of the digestive tract and evidence of signs and/or symptoms of cholinesterase inhibition.
INHALATION: Overexposure to the vapor or spray mist may be irritating to the respiratory tract. If inhaled, this substance is considered practically non-toxic to internal organs.
COMMENTS HEALTH: Depending upon the extent and degree of overexposure to acephate, signs and symptoms of cholinesterase inhibition can result following either ingestion, skin contact or inhalation routes of exposure. Signs and symptoms of cholinesterase inhibition can also result from either acute (one time), subchronic (repeated short-term) and chronic (daily life-time) exposure to the product.
Signs and symptoms of cholinesterase inhibition usually occur within 12 hours following overexposure. These effects may include, but may not be limited to, headache, dizziness, weakness, nausea, vomiting, diarrhea, constriction of the pupil of the eye, blurred or dark vision, excessive salivation or nasal discharge, profuse sweating and abdominal cramps. Incontinence, unconsciousness, convulsions and breathing difficulties are indicative of severe poisoning. In untreated severe poisoning, death is due to respiratory failure or cardiac arrest.
|
From MSDS
Signs and symptoms of cholinesterase inhibition can also result from either acute (one time), subchronic (repeated short-term) and chronic (daily life-time) exposure to the product.
Signs and symptoms of cholinesterase inhibition usually occur within 12 hours following overexposure. These effects may include, but may not be limited to, headache, dizziness, weakness, nausea, vomiting, diarrhea, constriction of the pupil of the eye, blurred or dark vision, excessive salivation or nasal discharge, profuse sweating and abdominal cramps. Incontinence, unconsciousness, convulsions and breathing difficulties are indicative of severe poisoning. In untreated severe poisoning, death is due to respiratory failure or cardiac arrest.
|
From MSDS
CARCINOGENICITY COMMENTS:
EPA has classed acephate in category C - possible human carcinogen, based on the increased incidence of liver tumors observed in the high dose, 1000 ppm (37.5 mg/kg/dy), female mice in the lifetime feeding study. Acephate was not carcinogenic in the other female and male mouse dose levels or the rat lifetime feeding study.
|
From MSDS
EYES: Immediately hold eyelids open and flush eyes with fresh water for at least 15 minutes. Remove contact lenses if worn. Get medical attention immediately.
SKIN: If on skin, wash with plenty of soap and water.
INGESTION: If swallowed contact physician, Poison Control Center, or emergency clinic before inducing vomiting. Give water or milk to drink and induce vomiting by touching back of throat with finger, or by administering syrup of ipecac. Do not induce vomiting or give anything by mouth to an unconscious person. If medical advice cannot be obtained, take person and product container to the nearest medical emergency treatment facility.
INHALATION: If respiratory discomfort or irritation occurs, move the person to fresh air. See a doctor if discomfort or irritation continues.
NOTES TO PHYSICIAN: This material contains a cholinesterase inhibitor. Measurement of blood cholinesterase activity may be useful in monitoring exposure. If signs and/or symptoms of cholinesterase inhibition appear, atropine sulfate is antidotal. 2-PAM (PROTOPAM) is also antidotal and may be used in conjunction with atropine but should not be used alone.
ADDITIONAL INFORMATION: In case of medical emergencies involving this product, call day or night, (800) 225-2883.
|
| 1 |
| 3 |
| 0 |
0 = Minimal; 1 = Slight; 2 = Moderate; 3 = Serious; 4 = Severe;
N = No information provided by manufacturer; * = Chronic Health Hazard |
| 2001-06-26 |
|
|
|
|
|
|
|
|
Handling/Disposal
|
From MSDS
GENERAL PROCEDURES: Keep pesticide in original container. Do not put concentrate or dilute into food or drink containers. Avoid contamination of feed and foodstuffs. Store in a cool, dry place, preferably locked storage area.
ECOTOXICOLOGICAL INFORMATION: This pesticide is toxic to birds. Do not apply directly to water. Do not contaminate water by cleaning of equipment or disposal of wastes. This product is highly toxic to bees exposed to direct treatment or residues on blooming crops or weeds.
|
From MSDS
The Solaris Group is committed to responsible environmental practices and recommends that all of the product be used up, carefully following all label directions and precautions.
If necessary to dispose of partially filled product container, then securely wrap it in several layers of newspaper and discard in trash.
EMPTY CONTAINER: Do not reuse container. Rinse thoroughly before discarding in trash.
|
|
|
|
|
|
|
|
|
Ingredients from MSDS/Label
|
| Chemical | CAS No / Unique ID | Percent |
| Acephate | 030560-19-1 | 9.4 |
|
|
|
|
|
|
|
|
Home
| Brands | Manufacturers
| Ingredients | Health
Effects
|
|
